China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.22%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has an Asset Resilience Ratio of 5.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of China Resources Sanjiu Medical & Pharmac to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥2.95 Billion
≈ $431.95 Million USD Cash + Short-term Investments

Total Assets

CN¥56.56 Billion
≈ $8.28 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See China Resources Sanjiu Medical & Pharmac (000999) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down China Resources Sanjiu Medical & Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see China Resources Sanjiu Medical & Pharmac market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥2.95 Billion 5.22%
Total Liquid Assets CN¥2.95 Billion 5.22%

Asset Resilience Insights

  • Limited Liquidity: China Resources Sanjiu Medical & Pharmaceutical Co Ltd maintains only 5.22% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
SIMCERE PHARMAC. GRP LTD
F:S2P
Drug Manufacturers - Specialty & Generic 0.44%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%

Annual Asset Resilience Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for China Resources Sanjiu Medical & Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.18% CN¥1.68 Billion
≈ $245.45 Million
CN¥40.08 Billion
≈ $5.87 Billion
+0.56pp
2023-12-31 3.63% CN¥1.46 Billion
≈ $213.06 Million
CN¥40.15 Billion
≈ $5.87 Billion
-1.39pp
2021-12-31 5.01% CN¥1.22 Billion
≈ $178.35 Million
CN¥24.31 Billion
≈ $3.56 Billion
+4.10pp
2020-12-31 0.91% CN¥200.18 Million
≈ $29.29 Million
CN¥22.01 Billion
≈ $3.22 Billion
-2.04pp
2016-12-31 2.95% CN¥400.00 Million
≈ $58.53 Million
CN¥13.55 Billion
≈ $1.98 Billion
-4.12pp
2015-12-31 7.07% CN¥850.00 Million
≈ $124.38 Million
CN¥12.02 Billion
≈ $1.76 Billion
-3.24pp
2014-12-31 10.31% CN¥1.10 Billion
≈ $160.96 Million
CN¥10.67 Billion
≈ $1.56 Billion
+10.23pp
2006-12-31 0.08% CN¥5.65 Million
≈ $827.07K
CN¥7.05 Billion
≈ $1.03 Billion
+0.00pp
2005-12-31 0.08% CN¥5.33 Million
≈ $780.39K
CN¥7.04 Billion
≈ $1.03 Billion
+0.00pp
2002-12-31 0.07% CN¥5.02 Million
≈ $734.12K
CN¥6.85 Billion
≈ $1.00 Billion
--
pp = percentage points

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.72 Billion
CN¥39.08 Billion CNY
Market Cap Rank
#3300 Global
#468 in China
Share Price
CN¥23.48
Change (1 day)
-1.30%
52-Week Range
CN¥23.48 - CN¥32.16
All Time High
CN¥1328.34
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more